Dermatology Times, November 2018 (Vol. 39, No. 11)

Low-dose bleomycin injections used to treat venous and venous lymphatic malformations might have an unanticipated side effect, according to recent research.

Investigators from the Health Hazard Evaluation Program of the Centers for Disease Control and Prevention recently issued these safety recommendations for tattoo removal.

Older skin might heal more slowly, but it heals with less scarring than younger skin, according to new research.

Topical sirolimus may provide a less-invasive treatment option for patients with angiofibroma, according to recent studies.

Wound healing is impaired in both psoriasis and multiple sclerosis. Understanding the pathophysiology of these two chronic conditions is vital to generating and improving treatment targets.

Dermatologists must be able to distinguish between infected and noninfected diabetic foot ulcers because whether or not a DFU is infected can help determine treatment protocol, says Warrent S. Joseph, D.P.M, FIDSA. 

Protease modulating therapies are used to assist in venous leg ulcer closure, but a recent review suggests that physicians should reexamine the biomarker's role in targeted chronic wound healing therapies.

Dr. Matt Davidson, Ph.D., wanted to find an effective and affortable treatment for the recurring common warts on his hands, which has lead him to become one of the youngest, if not youngest, pharmaceutical company pioneers in the country. 

The Food and Drug Administration (FDA) approved sarecycline (Seysara, Almirall, S.A.) in October for the treatment of non-nodular moderate-to-severe acne vulgaris in patients 9 years of age and older, according to a company news release.

Victor Desmond Mandel, M.D. and colleagues describe a reconstruction strategy for chronic infected neoplastic ulcers of the lower extremities using a dermal matrix and a unique postoperative dressing protocol.

Some believe that all skincare products should be approved by the FDA, but is the regulation of cosmetics really necessary?

I have pending malpractice lawsuits after opening a medical spa. What are my legal issues?

In this month's Innovation Column, Drs. Steve Xu and William Ju discuss the need for entrepreneurship education in medical school and residency training.

Identifying the presence of bacterial and fungal species improves antimicrobial therapy, according to a recent review published in the July issue of Advances in Wound Care.

Studies indicate physicians are fried, but a new review says it’s not as bad as it sounds.

Is it just a “spot” or precancerous lesion? Two physicians debate how best to treat actinic keratosis in a talk given at EADV last week.

There are many non-surgical treatments for basal cell carcinomas, but a physician reporting at EADV last week said new treatments should be compared against surgery, which has the highest cure rate and lowest rate of recurrence.

A pregnancy-associated melanoma (PAM) prognosis does not appear to be worse than melanoma in non-pregnant controls, researchers reported at EADV. Nonetheless, measures should be taken to protect the fetus in the treatment and imaging of PAM.

EADV report summarizes the latest advances in laser technology for tattoo removal.

Life-threatening emergency cases may be rare, but they can be complex. At EADV this week, experts review cases physicians should be aware of.

A study presented at EADV in Paris today showed that dupilumab met its primary endpoints in a phase three study of adolescents with moderate-to-severe atopic dermatitis.

EADV report shows that two JAK inhibitors reverses alopecia areata in some patients.

With immunotherapy as a key treatment for melanoma, dermatologists should be prepared to treat its cutaneous side effects and refer for adrenal sufficiency, uveitis, thyroid disease and other non-cutaneous side effects.

Checkpoint inhibitors have clearly changed the prognosis of melanoma, yet the search for evidence-based answers to these and other questions regarding their use continues, experts report at EADV this week.

Risankizumab performed better in treating psoriasis that appears on the nails, hands and feet, palms and scalp sores.